Edwards Lifesciences, Bay Labs ink cardio-focused collab AI-dev deal

Edwards Lifesciences’ (NYSE:EW) and  cardiovascular artificial intelligence medtech firm Bay Labs, have inked a multi-faceted collaborative cardiovascular-focused development deal, Bay Labs said today.